Desensitization of brain insulin receptor Effect on glucose/energy and related metabolism

  • S. Hoyer
  • D. Müller
  • K. Plaschke
Part of the Journal of Neural Transmission book series (NEURAL SUPPL, volume 44)


The overall majority of cases of Alzheimer disease are not caused by genetic abnormalities. A pluricausal etiology is assumed, and the age factor may be of pivotal significance. Aging leads to inherent changes in basic metabolic principles, including the functionally most important cerebral glucose/energy metabolism. Experimentally induced perturbation of the neuronal control over the glucose metabolism by means of intracerebroventricular administration of streptozotocin leads to cascade-like abnormalities in glucose breakdown and energy formation and in membrane phospholipid and monoaminergic catecholamine metabolism, which closely resemble the disturbances found in sporadic Alzheimer disease. It is concluded that this model is a good tool for in vivo study of the cellular events characteristic for this human neurodegenerative disorder.


Entorhinal Cortex Cerebral Glucose Metabolism Cerebral Glucose Utilization Related Metabolism Sporadic Alzheimer Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Beyreuther K, Masters CL (1991) Amyloid precursor protein (APP) and A4 amyloid in the etiology of Alzheimer’s disease: precursor-product relationships in the derangement of neuronal function. Brain Pathol 1: 241–251PubMedCrossRefGoogle Scholar
  2. Bolaffi JL, Nagamatsu S, Harris J, Grodsky GM (1987) Protection by thymidine, an inhibitor of poly adenosine diphosphate ribosylation, of streptozotocin inhibition of insulin secretion. Endocrinology 120: 2117–2122PubMedCrossRefGoogle Scholar
  3. Bowen DM, White P, Spillane J A, Goodhardt MJ, Curzon G, Iwangoff P, Meier-Ruge W, Davison AN (1979) Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet i: 11–14Google Scholar
  4. Brown GG, Levine SR, Gorell JM, Pettegrew JW, Gdowski JW, Bueri JA, Helpern JA, Welch KMA (1989) In vivo 31P NMR profiles of Alzheimer’s disease and multiple subcortical infarct dementia. Neurology 39: 1423–1427PubMedGoogle Scholar
  5. Czech C, Masters C, Beyreuther K (1994) Alzheimer’s disease and transgenic mice. J Neural Transm [Suppl] 44 (this volume)Google Scholar
  6. Ding A, Nitsch R, Hoyer S (1992) Changes in brain monoaminergic neurotransmitter concentrations in rat after intracerebroventricular injection of streptozotocin. J Cereb Blood Flow Metab 12: 103–109PubMedCrossRefGoogle Scholar
  7. Erecinska M, Silver IA (1989) ATP and brain function. J Cereb Blood Flow Metab 9: 2–19PubMedCrossRefGoogle Scholar
  8. Evans DA, Funkenstein H, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO (1989) Prevalence of Alzheimer’s disease in a community population of older persons. Higher than previously reported. J Am Med Ass 262: 2551–2556CrossRefGoogle Scholar
  9. Gertz HJ, Cervos-Navarro J, Frydl V, Schultz F (1985) Glycogen accumulation of the aging human brain. Mech Age Dev 31: 25–35CrossRefGoogle Scholar
  10. Gibson GE, Sheu KFR, Blass JP, Baker A, Carlson KC, Harding B, Perrino P (1988) Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer’s disease. Arch Neurol 45: 836–840PubMedCrossRefGoogle Scholar
  11. Gottfries CG (1990) Disturbance of the 5-hydroxy-tryptamine metabolism in brains from patients with Alzheimer’s dementia. J Neural Transm [Suppl] 30: 33–43Google Scholar
  12. Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharmacol Sci 12: 383–388PubMedCrossRefGoogle Scholar
  13. Havrankova J, Roth J, Brownstein MJ (1978) Insulin receptors are widely distributed in the central nervous system of rat. Nature 272: 827–829PubMedCrossRefGoogle Scholar
  14. Hoyer S (1988) Glucose and related brain metabolism in dementia of Alzheimer type and its morphological significance. Age 11: 158–166CrossRefGoogle Scholar
  15. Hoyer S (1992a) The biology of the ageing brain. Oxidative and related metabolism. Eur J Gerontol 1: 157–165Google Scholar
  16. Hoyer S (1992b) Oxidative energy metabolism in Alzheimer brain. Studies in early-onset and late-onset cases. Mol Chem Neuropathol 16: 207–224PubMedCrossRefGoogle Scholar
  17. Hoyer S, Nitsch R (1989) Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type. J Neural Transm 75: 227–232PubMedCrossRefGoogle Scholar
  18. Hoyer S, Nitsch R, Oesterreich K (1990) Ammonia is endogenously generated in the brain in the presence of presumed and verified dementia of Alzheimer type. Neurosci Lett 117: 358–362PubMedCrossRefGoogle Scholar
  19. Hoyer S, Nitsch R, Oesterreich K (1991) Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases. J Neural Transm [P-D Sect] 3: 1–14CrossRefGoogle Scholar
  20. Hoyer S, Oesterreich K, Wagner O (1988) Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type? J Neurol 235: 143–148PubMedCrossRefGoogle Scholar
  21. Hoyer S, Prem L, Sorbi S, Amaducci L (1993) Stimulation of glycolytic key enzymes in cerebral cortex by insulin. NeuroReport 4: 991–993Google Scholar
  22. Junod A, Lambert AE, Stauffacher W, Renold AE (1968) Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J Clin Invest 48: 2129–2139CrossRefGoogle Scholar
  23. Kadowaki T, Kasuga M, Akanuma Y, Ezaki O, Takafu F (1984) Decreased auto- phosphorylation of the insulin receptor-kinase in streptozotocin diabetic rats. J Biol Chem 259: 14208–14216PubMedGoogle Scholar
  24. Kumar A, Schapiro MB, Grady C, Haxby JV, Wagner E, Salerno JA, Friedland RP, Rapoport SI (1991) High-resolution PET studies in Alzheimer’s disease. Neuropsy- chopharmacology 4: 35–46Google Scholar
  25. Liguri G, Taddei N, Nassi P, Latorraca S, Nediani C, Sorbi S (1990) Changes in Na+, K+-ATPase, Ca2+-ATPase and some soluble enzymes related to energy metabolism in brains of patients with Alzheimer’s disease. Neurosci Lett 112: 338–342PubMedCrossRefGoogle Scholar
  26. Mann DMA, Sumpter PQ, Davies CA, Yates PO (1987) Glycogen accumulation in the cerebral cortex in Alzheimer’s disease. Acta Neuropathol 73: 181–184PubMedCrossRefGoogle Scholar
  27. Marcus DL, deLeon MJ, Goldman J, Logan J, Christman DR, Wolf AP, Fowler JS, Hunter K, Tsai J, Pearson J, Freedman ML (1989) Altered glucose metabolism in microvessels from patients with Alzheimer’s disease. Ann Neurol 26: 91–94PubMedCrossRefGoogle Scholar
  28. Marcus DL, deLeon M, Swerdlow R, Kaplan H, Tsai J, Freedman ML (1988) Decreased brain glucose metabolism in vivo and in microvessels in patients with Alzheimer’s disease. Clin Res 36: 486AGoogle Scholar
  29. Mielke R, Herholz K, Grond M, Kessler J, Heiss WD (1992) Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type. Neurobiol Aging 13: 93–98PubMedCrossRefGoogle Scholar
  30. Mordes JP, Rossini RA (1981) Animal model of diabetes. Am J Med 70: 353–360PubMedCrossRefGoogle Scholar
  31. Murphey DGM, Bottomley PA, Salerno JA, DeCarli C, Mentis MJ, Grady CL, Teichberg D, Giacometti KR, Rosenberg JM, Hardy CJ, Schapiro MB, Rapoport SI, Alger JR, Horwitz B (1993) An in vivo study of phophorus and glucose metabolism in Alzheimer’s disease using magnetic resonance spectroscopy and PET. Arch Gen Psychiatry 50: 341–349CrossRefGoogle Scholar
  32. Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ (1992) Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci USA 89: 1671–1675PubMedCrossRefGoogle Scholar
  33. Nitsch R, Hoyer S (1991) Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex. Neurosci Lett 128: 199–202PubMedCrossRefGoogle Scholar
  34. Palmer AM, Stratmann GC, Procter AW, Bowen DM (1988) Possible neurotransmitter basis of behavioral changes in Alzheimer’s disease. Ann Neurol 23: 616–620PubMedCrossRefGoogle Scholar
  35. Perry EK, Perry RH, Tomlinson BE, Blessed G, Gibson PH (1980) Coenzyme A-acetylating enzymes in Alzheimer’s disease: possible cholinergic “compartment” of pyruvate dehydrogenase. Neurosci Lett 18: 105–110PubMedCrossRefGoogle Scholar
  36. Plaschke K, Hoyer S (1993) Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int J Dev Neurosci 11: 477–483PubMedCrossRefGoogle Scholar
  37. Quon D, Wang Y, Catalano R, Scardina JM, Murakami K, Cordell B (1991) Formation of beta-amyloid protein deposits in brains of transgenic mice. Nature 352: 239–241PubMedCrossRefGoogle Scholar
  38. Reinikainen KJ, Paljarvi L, Halonen T, Malminen O, Kosma VM, Laakso M, Riekkinen PJ (1988) Dopaminergic system and monoamine oxidase-B activity in Alzheimer’s disease. Neurobiol Aging 9: 245–252PubMedCrossRefGoogle Scholar
  39. Riederer P, Sofic E, Moll G, Freyberger A, Wichart I, Gsell W, Jellinger K, Heben- streit G, Youdim MBH (1990) Senile dementia of Alzheimer’s type and Parkinson’s disease: neurochemical overlaps and specific differences. In: Dostert P, Riederer P (eds) Early markers in Parkinson’s and Alzheimer diseases. Springer, Wien New York, pp 221–232 (New vistas in drug research, vol 1 )Google Scholar
  40. Sims NR, Blass JP, Murphy C, Bowen DM, Neary D (1987) Phosphofructokinase activity in the brain in Alzheimer’s disease. Ann Neurol 21: 509–510PubMedCrossRefGoogle Scholar
  41. Sims NR, Bowen DM, Neary D, Davison AN (1983) Metabolic processes in Alzheimer’s disease: adenine nucleotide content and production of 14C02 from (U-14C) glucose in vitro in human neocortex. J Neurochem 41: 1329–1334PubMedCrossRefGoogle Scholar
  42. Small GW, Kuhl DE, Riege WH, Fujikawa DG, Ashford JW, Metter EJ, Mazziotta JC (1989) Cerebral glucose metabolic patterns in Alzheimer’s disease. Effect of gender and age at dementia onset. Arch Gen Psychiatry 46: 527–532PubMedCrossRefGoogle Scholar
  43. Sorbi S, Bird ED, Blass JP (1983) Decreased pyruvate dehydrogenase complex activityin Huntington and Alzheimer brain. Ann Neurol 13: 72–78PubMedCrossRefGoogle Scholar
  44. Storandt M, Bakman L, Baltes MM, Blass JP, Braak H, Gutzmann H, Hauw JJ, Hoyer S, Jorm AF, Kauss J, Kliegl R, Mountjoy CQ (1988) Relationships of normal aging and dementing diseases in later life. In: Henderson AS, Henderson JH (eds) Etiology of dementia of Alzheimer’s type. Wiley, Chichester, pp 231–239Google Scholar
  45. Yates CM, Butterworth J, Tennant MC, Gordon A (1990) Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer type and other dementias. J Neurochem 55: 1624–1630PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • S. Hoyer
    • 1
  • D. Müller
    • 1
  • K. Plaschke
    • 1
  1. 1.Department of Pathochemistry and General NeurochemistryUniversity of HeidelbergHeidelbergFederal Republic of Germany

Personalised recommendations